Watch for the Anticoagulant Bevyxxa During Transitions of Care

You may see some patients get Bevyxxa (beh-VYKE-sah, betrixaban), a new direct oral anticoagulant (DOAC), after hospital discharge.

It's not used the same way as other DOACs...Pradaxa (dabigatran), Xarelto (rivaroxaban), Eliquis (apixaban), or Savaysa (edoxaban).

Bevyxxa is only for "extended-duration" PREVENTION of venous thromboembolism (VTE) in certain hospitalized adults with multiple risk factors...such as reduced mobility plus older age and heart failure.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote